-
Something wrong with this record ?
Could pentraxin 3 be a new diagnostic marker for excessive inflammatory response in cardiac surgery
Z. Holubcova, P. Kunes, J. Mandak, M. Kolackova, C. Andrys, J. Krejsek, T. Holubec,
Language English Country Germany
Document type Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Biomarkers blood MeSH
- C-Reactive Protein metabolism MeSH
- Time Factors MeSH
- Adult MeSH
- Cardiac Surgical Procedures adverse effects MeSH
- Cardiopulmonary Bypass adverse effects MeSH
- Middle Aged MeSH
- Humans MeSH
- Inflammation Mediators blood MeSH
- Predictive Value of Tests MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Serum Amyloid P-Component metabolism MeSH
- Systemic Inflammatory Response Syndrome blood diagnosis etiology MeSH
- Treatment Outcome MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Comparative Study MeSH
BACKGROUND: The aim of this study was to compare the dynamics of two inflammatory response biomarkers pentraxin 3 (PTX3) and C-reactive protein (CRP) after cardiac surgery with particular regard to different postoperative clinical manifestation of inflammatory response. PATIENTS AND METHODS: In this study, 42 patients undergoing open heart surgery with the use of cardiopulmonary bypass were included and divided in two groups according to the extent of clinical manifestation of inflammatory response: Group A (n=21)-patients with different severity of systemic inflammatory response syndrome (SIRS) and Group B (n=21)-patients with uneventful postoperative period (no SIRS). The serum levels of PTX3 and CRP were evaluated and compared at the following time points: before and at the end of surgery, 6 hours, 1st, 3rd, and 7th day after surgery. RESULTS: The dynamics of CRP levels were comparable between both groups and showed the classical characteristics after cardiac surgery with a peak on the 3rd postoperative day (113 vs. 132 mg/L). In contrast, the dynamics of PTX3 showed an earlier increase of serum levels with the peak on the 1st postoperative day in both groups (36.3 vs. 42.7 ng/mL). Importantly, a significant difference of PTX3 levels was found on the 3rd postoperative day (31.1 vs. 7.0 ng/mL; p<0.006) between the two groups showing significantly delayed decrease of PTX3 levels in patients with SIRS (Group A). CONCLUSION: This study demonstrates considerably different dynamics of PTX3 levels after cardiac surgery in patients with SIRS and patients without SIRS, thus it may be indicative to start the appropriate therapy.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15031896
- 003
- CZ-PrNML
- 005
- 20151014130636.0
- 007
- ta
- 008
- 151005s2014 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1055/s-0034-1384668 $2 doi
- 035 __
- $a (PubMed)25148605
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Holubcova, Zdenka $u Department of Cardiac Surgery, Charles University in Prague, Faculty of Medicine and University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
- 245 10
- $a Could pentraxin 3 be a new diagnostic marker for excessive inflammatory response in cardiac surgery / $c Z. Holubcova, P. Kunes, J. Mandak, M. Kolackova, C. Andrys, J. Krejsek, T. Holubec,
- 520 9_
- $a BACKGROUND: The aim of this study was to compare the dynamics of two inflammatory response biomarkers pentraxin 3 (PTX3) and C-reactive protein (CRP) after cardiac surgery with particular regard to different postoperative clinical manifestation of inflammatory response. PATIENTS AND METHODS: In this study, 42 patients undergoing open heart surgery with the use of cardiopulmonary bypass were included and divided in two groups according to the extent of clinical manifestation of inflammatory response: Group A (n=21)-patients with different severity of systemic inflammatory response syndrome (SIRS) and Group B (n=21)-patients with uneventful postoperative period (no SIRS). The serum levels of PTX3 and CRP were evaluated and compared at the following time points: before and at the end of surgery, 6 hours, 1st, 3rd, and 7th day after surgery. RESULTS: The dynamics of CRP levels were comparable between both groups and showed the classical characteristics after cardiac surgery with a peak on the 3rd postoperative day (113 vs. 132 mg/L). In contrast, the dynamics of PTX3 showed an earlier increase of serum levels with the peak on the 1st postoperative day in both groups (36.3 vs. 42.7 ng/mL). Importantly, a significant difference of PTX3 levels was found on the 3rd postoperative day (31.1 vs. 7.0 ng/mL; p<0.006) between the two groups showing significantly delayed decrease of PTX3 levels in patients with SIRS (Group A). CONCLUSION: This study demonstrates considerably different dynamics of PTX3 levels after cardiac surgery in patients with SIRS and patients without SIRS, thus it may be indicative to start the appropriate therapy.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a biologické markery $x krev $7 D015415
- 650 _2
- $a C-reaktivní protein $x metabolismus $7 D002097
- 650 _2
- $a kardiochirurgické výkony $x škodlivé účinky $7 D006348
- 650 _2
- $a kardiopulmonální bypass $x škodlivé účinky $7 D002315
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mediátory zánětu $x krev $7 D018836
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a prediktivní hodnota testů $7 D011237
- 650 _2
- $a sérový amyloidový protein $x metabolismus $7 D000683
- 650 _2
- $a syndrom systémové zánětlivé reakce $x krev $x diagnóza $x etiologie $7 D018746
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kunes, Pavel $u Department of Cardiac Surgery, Charles University in Prague, Faculty of Medicine and University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
- 700 1_
- $a Mandak, Jiri $u Department of Cardiac Surgery, Charles University in Prague, Faculty of Medicine and University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
- 700 1_
- $a Kolackova, Martina $u Department of Clinical Immunology and Alergology, Charles University in Prague, Faculty of Medicine and University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
- 700 1_
- $a Andrýs, Ctirad $u Department of Clinical Immunology and Alergology, Charles University in Prague, Faculty of Medicine and University Hospital Hradec Kralove, Hradec Kralove, Czech Republic. $7 mzk2008430528
- 700 1_
- $a Krejsek, Jan $u Department of Clinical Immunology and Alergology, Charles University in Prague, Faculty of Medicine and University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
- 700 1_
- $a Holubec, Tomas $u Division of Cardiovascular Surgery, University Hospital Zurich, Zurich, Switzerland.
- 773 0_
- $w MED00010684 $t The Thoracic and cardiovascular surgeon $x 1439-1902 $g Roč. 62, č. 8 (2014), s. 670-6
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25148605 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20151005 $b ABA008
- 991 __
- $a 20151014130826 $b ABA008
- 999 __
- $a ok $b bmc $g 1092772 $s 915022
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 62 $c 8 $d 670-6 $e 20140822 $i 1439-1902 $m The thoracic and cardiovascular surgeon $n Thorac Cardiovasc Surg $x MED00010684
- LZP __
- $a Pubmed-20151005
